Contract awardedRadioisotopes
RMH - Radiopharmaceuticals Xiel
- The Royal Marsden NHS Foundation Trust
- London
- Direct award
- 12 March 2026 to 11 March 2028
Provision of specific radiopharmaceutical agents including Nanotop, MAG3, Tektrotyd, and Illuccix for clinical use. The contract involves the ongoing supply chain management and delivery of these medical products to support diagnostic imaging services.
- Awarded value
- £2.4m
- As published
- Published
- 12 February 2026
- Contract length
- 24 months
- Ends 11 March 2028